BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10894136)

  • 1. Magnetic resonance imaging facilitates breast conservation for occult breast cancer.
    Olson JA; Morris EA; Van Zee KJ; Linehan DC; Borgen PI
    Ann Surg Oncol; 2000 Jul; 7(6):411-5. PubMed ID: 10894136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Outcomes After Treatment for MRI Occult Breast Cancer (pT0N+).
    McCartan DP; Zabor EC; Morrow M; Van Zee KJ; El-Tamer MB
    Ann Surg Oncol; 2017 Oct; 24(11):3141-3147. PubMed ID: 28702770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI in patients with axillary metastases of occult breast carcinoma.
    Tilanus-Linthorst MM; Obdeijn AI; Bontenbal M; Oudkerk M
    Breast Cancer Res Treat; 1997 Jun; 44(2):179-82. PubMed ID: 9232276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography.
    Ko EY; Han BK; Shin JH; Kang SS
    Korean J Radiol; 2007; 8(5):382-9. PubMed ID: 17923780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult breast carcinoma presenting with axillary lymph node metastases.
    Medina-Franco H; Urist MM
    Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
    Pilewskie M; Jochelson M; Gooch JC; Patil S; Stempel M; Morrow M
    J Am Coll Surg; 2016 Feb; 222(2):138-45. PubMed ID: 26711795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of the breast in patients with occult primary breast carcinoma.
    Morris EA; Schwartz LH; Dershaw DD; van Zee KJ; Abramson AF; Liberman L
    Radiology; 1997 Nov; 205(2):437-40. PubMed ID: 9356625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography in diagnosis of occult adenocarcinoma of the breast.
    Block EF; Meyer MA
    Am Surg; 1998 Sep; 64(9):906-8. PubMed ID: 9731824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
    Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
    Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of occult breast carcinoma with irradiation therapy and axillary lymph node dissection].
    Sugiyama Y; Morifuji M; Tatsumoto N; Sasaki M; Naito H; Kai Y
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1287-9. PubMed ID: 16969026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
    He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
    Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult breast cancer presenting with axillary metastases. Updated management.
    Baron PL; Moore MP; Kinne DW; Candela FC; Osborne MP; Petrek JA
    Arch Surg; 1990 Feb; 125(2):210-4. PubMed ID: 2302061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.
    de Bresser J; de Vos B; van der Ent F; Hulsewé K
    Eur J Surg Oncol; 2010 Feb; 36(2):114-9. PubMed ID: 19822403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography in women with axillary lymphadenopathy and normal breasts on physical examination: value in detecting occult breast carcinoma.
    Leibman AJ; Kossoff MB
    AJR Am J Roentgenol; 1992 Sep; 159(3):493-5. PubMed ID: 1503012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult breast carcinoma presenting as axillary metastases.
    Foroudi F; Tiver KW
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):143-7. PubMed ID: 10758316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.